WallStreetZenWallStreetZen

NASDAQ: RPID
Rapid Micro Biosystems Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their RPID stock forecasts and price targets.

Forecast return on equity

Is RPID forecast to generate an efficient return?
Company
N/A
Industry
-0.02%
Market
20.28%

Forecast return on assets

Is RPID forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.02%

RPID revenue forecast

What is RPID's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$27.1M+20.44%
Avg 2 year Forecast
$36.6M+62.74%
Avg 3 year Forecast
$51.2M+127.49%
RPID's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RPID revenue growth forecast

How is RPID forecast to perform vs Medical Devices companies and vs the US market?
Company
30.06%
Industry
8.6%
Market
9.42%
RPID's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPID's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPID vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RPID$0.97N/AN/A
LFWD$5.00$9.00+80.00%Buy
ICAD$1.63N/AN/A
LUCD$0.81$2.75+239.51%Strong Buy
CUTR$2.21$7.67+246.92%Strong Buy

Rapid Micro Biosystems Stock Forecast FAQ

What is RPID's revenue growth forecast for 2024-2026?

(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 30.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.42%.

Rapid Micro Biosystems's revenue in 2024 is $22,519,000.On average, 2 Wall Street analysts forecast RPID's revenue for 2024 to be $1,152,572,338, with the lowest RPID revenue forecast at $1,147,430,151, and the highest RPID revenue forecast at $1,157,757,022. On average, 2 Wall Street analysts forecast RPID's revenue for 2025 to be $1,557,402,694, with the lowest RPID revenue forecast at $1,483,159,714, and the highest RPID revenue forecast at $1,631,645,675.

In 2026, RPID is forecast to generate $2,177,099,971 in revenue, with the lowest revenue forecast at $2,177,099,971 and the highest revenue forecast at $2,177,099,971.

If you're new to stock investing, here's how to buy Rapid Micro Biosystems stock.

What is RPID's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: RPID) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of -0.02%.

What is RPID's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: RPID) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.